Mobile

A double-blind (third party open), placebo-controlled, parallel group, multiple dose study to investigate the safety, toleration and pharmacokinetics of [S,S]-Reboxetine in young and elderly healthy v...

Update Il y a 5 ans
Reference: EUCTR2004-004232-31

A double-blind (third party open), placebo-controlled, parallel group, multiple dose study to investigate the safety, toleration and pharmacokinetics of [S,S]-Reboxetine in young and elderly healthy volunteers

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To investigate the safety and toleration of multiple oral doses of (+)-[S,S]-RBX administeredonce daily in an extended release formulation in young and elderly volunteers. To investigate the steady state pharmacokinetics of multiple oral doses of (+)-[S,S]-RBXadministered once daily in an extended release formulation in young and elderly volunteers.

Inclusion criteria

  • Postherpetic Neuralgia

Links